Swiss All Share Index

Swiss All Share Index handeln
18.164,82 PKT +460,10 PKT +2,60 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

ISIN CH0009111011


Analysen zu Swiss All Share Index-Werten

Datum Rating Analyst
25.04.12 UBS buy WestLB AG
25.04.12 Temenos equal-weight Morgan Stanley
25.04.12 Logitech underperform Cheuvreux SA
25.04.12 Lindt underperform Cheuvreux SA
25.04.12 ABB (Asea Brown Boveri) outperform Cheuvreux SA
25.04.12 ABB (Asea Brown Boveri) neutral Sarasin Research
25.04.12 ams-OSRAM buy Erste Group Bank
25.04.12 ABB (Asea Brown Boveri) hold ING
25.04.12 ABB (Asea Brown Boveri) buy Vontobel Research
25.04.12 ABB (Asea Brown Boveri) hold Société Générale Group S.A. (SG)
25.04.12 Temenos buy Vontobel Research
25.04.12 Novartis hold Vontobel Research
25.04.12 UBS hold Vontobel Research
25.04.12 Kühne + Nagel International neutral Sarasin Research
24.04.12 Novartis buy WestLB AG
24.04.12 Novartis halten Independent Research GmbH
24.04.12 Novartis buy Sarasin Research
24.04.12 Nestlé buy Sarasin Research
24.04.12 Swiss Re buy Vontobel Research
24.04.12 Nestlé halten Independent Research GmbH
24.04.12 BB Biotech buy Close Brothers Seydler Research AG
24.04.12 Nestlé buy Société Générale Group S.A. (SG)
24.04.12 Swisscom outperform Exane-BNP Paribas SA
24.04.12 Novartis underperform Cheuvreux SA
24.04.12 ams-OSRAM buy Vontobel Research
24.04.12 Swisscom equal-weight Morgan Stanley
24.04.12 Novartis hold Vontobel Research
24.04.12 Nestlé hold ING
23.04.12 Givaudan neutral Sarasin Research
23.04.12 Novartis buy Nomura
23.04.12 Novartis buy Sarasin Research
23.04.12 Nestlé outperform Cheuvreux SA
23.04.12 Swisscom buy Société Générale Group S.A. (SG)
23.04.12 Nestlé halten Independent Research GmbH
20.04.12 Nestlé buy Sarasin Research
20.04.12 Nestlé hold ING
20.04.12 ABB (Asea Brown Boveri) hold ING
19.04.12 BB Biotech kaufen Independent Research GmbH
19.04.12 Schindler buy Sarasin Research
18.04.12 Swiss Re underperform RBC Capital Markets